Skip to content

Clinical, Physiological and Prognostic Implication of Microvascular Status

Clinical, Physiological and Prognostic Implication of Index of Microcirculatory Resistance

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02186093
Enrollment
1197
Registered
2014-07-10
Start date
2009-04-30
Completion date
2020-11-30
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Coronary Artery Disease, Angina, Stable, Fractional Flow Reserve, Myocardial, Coronary Angiography

Brief summary

There are several physiologic parameters in evaluating cardiovascular disease. This study will reveal which parameter is the most proper value in predicting disease severity and risk factors of patients.

Detailed description

Fractional Flow Reserve (FFR), index of microcirculatory resistance (IMR), and coronary flow reserve (CFR) will be measured in stable angina patients before coronary intervention. Relationship between angiographic characteristics of patients and FFR, IMR, CFR will be analyzed. Comparison of risk factors and prognosis between parameters will be also analyzed. This study will evaluate that which parameter is correlate with disease severity and risk factors of patients.

Interventions

None listed

Sponsors

Ulsan University Hospital
CollaboratorOTHER
Keimyung University
CollaboratorOTHER
Inje University
CollaboratorOTHER
Stanford University
CollaboratorOTHER
University of Glasgow
CollaboratorOTHER
Hospital San Carlos, Madrid
CollaboratorOTHER
Royal Prince Alfred Hospital, Sydney, Australia
CollaboratorOTHER
Samsung Medical Center
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 * Patients with stable angina * FFR, IMR, CFR were measured before coronary intervention

Exclusion criteria

* Patients who have severe side effects or contraindication to hyperemic agents (ex. adenosine) * Patients with hemodynamic instability * elevation of cardiac enzymes, evidence of acute MI, or a culprit vessel of acute coronary syndrome

Design outcomes

Primary

MeasureTime frame
Spearman correlation coefficient between FFR, IMR, CFR and angiographic severityduring coronary angiography

Countries

South Korea

Contacts

Primary ContactJoo Myung Lee, MD, MPH, PhD
drone80@hanmail.net82-10-8884-8439
Backup ContactBon-Kwon Koo, MD, PhD
bkkoo@snu.ac.kr82-2-2072-2062

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026